{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:09:49Z","timestamp":1788923389057,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/s11916-001-0038-6","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T02:24:25Z","timestamp":1180837465000},"page":"241-249","source":"Crossref","is-referenced-by-count":30,"title":["Neuraxial infusion in patients with chronic intractable cancer and noncancer pain"],"prefix":"10.1007","volume":"5","author":[{"given":"Richard K.","family":"Osenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"38_CR1","first-page":"81","volume":"21","author":"JC Eisenach","year":"1996","unstructured":"Eisenach JC: Three novel spinal analgesics: clonidine, neostigmine, amitriptyline. Reg Anesth 1996, 21:81\u201383.","journal-title":"Reg Anesth"},{"key":"38_CR2","first-page":"151","volume-title":"Progress in Pain Management and Research","author":"Tl Yaksh","year":"1994","unstructured":"Yaksh Tl, Mamberg AB: Interaction of spinal modulatory receptor systems. In Progress in Pain Management and Research, vol 1. Edited by Fields HL, Liebeskind JC. Seattle: IASP Press; 1994:151\u2013171."},{"key":"38_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000542-199302000-00011","volume":"78","author":"J Eisenach","year":"1993","unstructured":"Eisenach J, Detweiler D, Hood D: Hemodynamic and analgesic effects of epidurally administered clonidine. Anesthesiology 1993, 78:277\u2013287.","journal-title":"Anesthesiology"},{"key":"38_CR4","first-page":"1303","volume":"65","author":"T Gordh","year":"1986","unstructured":"Gordh T, Post C, Olsson Y: Evaluation of the toxicity of subarachnoid clonidine, guanfacine, and a substance P antagonist on rat spinal cord and nerve roots: light and electron microscopic observations after chronic intrathecal administration. Anesth Analg 1986, 65:1303\u20131311.","journal-title":"Anesth Analg"},{"key":"38_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1046\/j.1525-1403.1999.00085.x","volume":"2","author":"S Hassenbusch","year":"1999","unstructured":"Hassenbusch S, Garber J, Buchser E, et al.: Alternative agents for the treatment of pain. Neuromodulation 1999, 2:85\u201391. An excellent review of some of the alternative agents that are currently being used or developed for IT analgesia.","journal-title":"Neuromodulation"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3959(94)90059-0","volume":"59","author":"PJ Siddal","year":"1994","unstructured":"Siddal PJ, Rutkowski S, Cousins MJ: Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report. Pain 1994, 59:147\u201348.","journal-title":"Pain"},{"key":"38_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00000539-199809000-00018","volume":"87","author":"JC Eisenach","year":"1998","unstructured":"Eisenach JC, Hood DD, Curry R: Intrathecal, but not intravenous clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesth Analg 1998, 87:591\u2013596.","journal-title":"Anesth Analg"},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00000542-199409000-00011","volume":"81","author":"KS Filos","year":"1994","unstructured":"Filos KS, Goudas LC, Patroni O, Polyzou V: Hemodynamic and analgesic profile after intrathecal clonidine in humans. Anesthesiology 1994, 81:591\u2013601.","journal-title":"Anesthesiology"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/00000542-199312000-00005","volume":"179","author":"RL Rauck","year":"1993","unstructured":"Rauck RL, Eisenach JC, Jackson K, Young LD: Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993, 179:1163\u20131169.","journal-title":"Anesthesiology"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3171\/jns.1995.82.4.0595","volume":"92","author":"JW Leiphart","year":"1995","unstructured":"Leiphart JW, Dills CV, Zikel OM, et al.: A comparison of intrathecally administered narcotic and nonnarcotic analgesics for experimental chronic neuropathic pain. J Neurosurg 1995, 92:595\u2013599.","journal-title":"J Neurosurg"},{"key":"38_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","volume":"33","author":"GJ Bennett","year":"1988","unstructured":"Bennett GJ, Xie YK: A peripheral mononeuropathy in rat that produces disorders and pain sensation like those seen in man. Pain 1988, 33:87\u2013107.","journal-title":"Pain"},{"key":"38_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1213\/00000539-199307000-00021","volume":"77","author":"MJC Puke","year":"1993","unstructured":"Puke MJC, Zsuzanna W: The differential effects of morphine and the a-2 adrenoreceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesth Analg 1993, 77:104\u2013109.","journal-title":"Anesth Analg"},{"key":"38_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0304-3959(90)91093-X","volume":"42","author":"J Sagen","year":"1990","unstructured":"Sagen J, Wang H, Pappas GD: Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. Pain 1990, 42:69\u201379.","journal-title":"Pain"},{"key":"38_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/00000542-199611000-00007","volume":"85","author":"E Buchser","year":"1996","unstructured":"Buchser E, Goddard M, Heyd B, et al.: Immunoisolated xenogeneic chromaffin cell therapy for chronic pain. Anesthesiology 1996, 85:1005\u20131012.","journal-title":"Anesthesiology"},{"key":"38_CR15","first-page":"1243","volume":"279","author":"S Bowersox","year":"1996","unstructured":"Bowersox S, Gadbois T, Singh T, et al.: Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent, and neuropathic pain. J Pharmacol Exper Ther 1996, 279:1243\u20131249.","journal-title":"J Pharmacol Exper Ther"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1523\/JNEUROSCI.14-08-04882.1994","volume":"14","author":"A Malmberg","year":"1994","unstructured":"Malmberg A, Yaksh T: Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci 1994, 14:4882\u20134890.","journal-title":"J Neurosci"},{"key":"38_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/00002508-199709000-00012","volume":"13","author":"WG Brose","year":"1997","unstructured":"Brose WG, Gutlove DP, Luther RR, et al.: Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion. Clin J Pain 1997, 13:256\u2013259.","journal-title":"Clin J Pain"},{"key":"38_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/00005344-199709000-00019","volume":"30","author":"D McGuire","year":"1997","unstructured":"McGuire D, Bowersox SS, Fellman JD, Luther RR: Sympatholysis after neuron-specific, N-type, voltage-sensitive, calcium channel blockade: first demonstration of N-channel function in humans. J Cadiovasc Pharmacol 1997, 30:400\u2013403.","journal-title":"J Cadiovasc Pharmacol"},{"key":"38_CR19","unstructured":"Staats P, Charapata S, Presley R: Chronic, intractable neuropathic pain: marked analgesic efficacy of ziconotide. 4th International Congress of the International Neuromodulation Society. Lucerne: International Neuromodulation Society; 1998. Presents some important findings regarding the use of IT SNX-111 for the treatment of pain. It is a well-done study that provides an objective assessment of efficacy and toxicity of SNX-111."},{"key":"38_CR20","unstructured":"Brose W, Pfeifer B, Hassenbusch S: SNX-111 produces analgesia in patients with intractable pain: phase I\/II results [abstract]. 11th World Congress of Anesthesiologists. Australia: World Congress of Anesthesiologists; 1996."},{"key":"38_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF03011718","volume":"43","author":"CH Yang","year":"1996","unstructured":"Yang CH, Wong CS, Chang JY, Ho ST: Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anesth 1996, 43:379\u2013383.","journal-title":"Can J Anesth"},{"key":"38_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0304-3959(92)90266-E","volume":"51","author":"JD Kristensen","year":"1992","unstructured":"Kristensen JD, Svensson B, Gordh T: The NMDA-receptor antagonist CPP abolishes neurogenic \"wind-up\" pain after intrathecal administration in humans. Pain 1992, 51:249\u2013253.","journal-title":"Pain"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.STR.26.3.503","volume":"26","author":"K Muir","year":"1995","unstructured":"Muir K, Lees K: Clinical experience with excitatory amino acid antagonist drugs. Stroke 1995, 26:503\u2013513.","journal-title":"Stroke"},{"key":"38_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1046\/j.1525-1403.1999.00230.x","volume":"2","author":"S Hassenbusch","year":"1999","unstructured":"Hassenbusch S, Satterfield WC, Gradert TL, et al.: Preclinical toxicity study of intrathecal administration of the painrelievers dextrorphan, dextromethorphan, and memantine in the sheep model. Neuromodulation 1999, 2:230\u2013239. Provides important safety and toxicity information on the IT use of several NMDA receptor antagonists that have been tested. The paper presents the data from a sheep model, which is chosen because of the similarities of the spinal cord to humans.","journal-title":"Neuromodulation"},{"key":"38_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0306-4522(90)90165-Z","volume":"34","author":"J Sandkuhler","year":"1990","unstructured":"Sandkuhler J, Fu Q-G, Helmchen C: Spinal somatostatin superfusion in vivo affects activity of cat nociceptive dorsal horn neurons: comparison with spinal morphine. Neuroscience 1990, 34:565\u2013576.","journal-title":"Neuroscience"},{"key":"38_CR26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/00000542-199409000-00004","volume":"81","author":"P Mollenholt","year":"1994","unstructured":"Mollenholt P, Rawal N, Gordh T, Olsson Y: Intrathecal and epidural somatostatin for patients with cancer. Analgesic effects and postmortem neuropathological investigations of spinal cord and nerve roots. Anesthesiology 1994, 81:534\u2013542.","journal-title":"Anesthesiology"},{"key":"38_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3959(92)90182-B","volume":"49","author":"R Penn","year":"1992","unstructured":"Penn R, Paice J, Kroin JS: Octreotide: a potent new non-opiate analgesic for intrathecal infusion. Pain 1992, 49:13\u201319.","journal-title":"Pain"},{"key":"38_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00006123-199601000-00047","volume":"38","author":"J Paince","year":"1996","unstructured":"Paince J, Penn R, Kroin JS: Intrathecal octreotide for relief of intractable nonmalignant pain: 5-year experience with two cases. Neurosurgery 1996, 38:203\u2013207.","journal-title":"Neurosurgery"},{"key":"38_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000098905","volume":"65","author":"T Taira","year":"1995","unstructured":"Taira T, Kawamura H, Tanikawa T, et al.: A new approach to control central deafferentation pain: spinal intrathecal baclofen. Stereotact Funct Neurosurg 1995, 65:101\u2013105.","journal-title":"Stereotact Funct Neurosurg"},{"key":"38_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00002508-199212000-00008","volume":"8","author":"RM Herman","year":"1992","unstructured":"Herman RM, D\u2019Luzansky SC, Ippolito R: Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 1992, 8:381\u2013382.","journal-title":"Clin J Pain"},{"key":"38_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0885-3924(96)00152-2","volume":"12","author":"PG Loubsher","year":"1996","unstructured":"Loubsher PG, Akman NM: Effects of intrathecal baclofen on chronic spinal cord injury pain. J Pain Symptom Manage 1996, 12:241\u2013247.","journal-title":"J Pain Symptom Manage"},{"key":"38_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(92)90125-U","volume":"48","author":"JM Serrao","year":"1992","unstructured":"Serrao JM, Marks RL, Morley SJ, Goodchild CS: Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study. Pain 1992, 48:5\u201312.","journal-title":"Pain"},{"key":"38_CR33","unstructured":"Staats P, Mitchell V: Future directions for intrathecal therapies. Prog Anesthesiol."},{"key":"38_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00000542-199502000-00003","volume":"82","author":"DD Hood","year":"1995","unstructured":"Hood DD, Eisenach JC, Tuttle R: Phase I safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology 1995, 82:331\u2013343.","journal-title":"Anesthesiology"},{"key":"38_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/00000539-199907000-00023","volume":"89","author":"M Belfrage","year":"1999","unstructured":"Belfrage M, Segerdahl M, Arner S, Sollevi A: The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain. Anesth Analg 1999, 89:136\u2013142. An interesting paper that suggests that IT adenosine may be particularly effective in patients with neuropathic pain and provides the basis for further investigation into this agent on a larger scale.","journal-title":"Anesth Analg"},{"key":"38_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0304-3959(93)90028-N","volume":"54","author":"TL Yaksh","year":"1993","unstructured":"Yaksh TL, Malmberg AB: Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces anti-nociception in the formalin test in rats. Pain 1993, 54:291\u2013300.","journal-title":"Pain"},{"key":"38_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00000542-199308000-00012","volume":"79","author":"AB Malmberg","year":"1993","unstructured":"Malmberg AB, Yaksh TL: Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobiologic analysis of the NSAID interaction. Anesthesiology 1993, 79:211\u2013213.","journal-title":"Anesthesiology"},{"key":"38_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0006-8993(94)90393-X","volume":"653","author":"LC Yu","year":"1994","unstructured":"Yu LC, Hansson P, Lundeberg T: The calcitonin gene-related peptide antagonist CGRP 8-37 increases the latency to withdrawal responses in rats. Brain Res 1994, 653:223\u2013230.","journal-title":"Brain Res"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-001-0038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-001-0038-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-001-0038-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-001-0038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:50:18Z","timestamp":1652615418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-001-0038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11916-001-0038-6","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}